Efficacy of combined treatment of intramuscular testosterone injection and testosterone ointment application for late-onset hypogonadism: an open-labeled, randomized, crossover study
Authors:
- 18 September 2019
- journal article
- research article
- Published by Taylor & Francis in The Aging Male
- Vol. 23 (5) , 1059-1065
Abstract
Introduction: The best method for administering testosterone replacement therapy (TRT) for late-onset hypogonadism (LOH) remains controversial. This study aimed to compare the efficacy and safety of a combined treatment (CT) involving intramuscular testosterone injection and testosterone ointment application [Glowmin® (GL)] with intramuscular injection monotherapy (IMIM). Materials and methods: Patients were randomly assigned as follows: Group 1 received IMIM for 12 weeks and CT for 12 weeks and Group 2 received CT for 12 weeks and IMIM for 12 weeks. Patients were then asked about their treatment preferences: (A) IMIM, (B) a combination of IMIM and ointment, or (C) either A or B. Results: Patients (n = 43) completed the study without any adverse effects. No significant differences between each treatment period were found. In Group 1, most patients chose B (n = 13) while in Group 2, most chose A (n = 10). In each group, patients preferred the second treatment phase; however, statistical significance was not reached between A and B (Group 1, p = 0.11 and Group 2, p = 0.47, respectively). Conclusion: TRT by CT is compatible with TRT by IMIM. Patients who cannot continue TRT because of polycythemia from IMIM may be suited to CT.Keywords
This publication has 22 references indexed in Scilit:
- Pharmacology of testosterone replacement therapy preparationsTranslational Andrology and Urology, 2016
- Recent topics related to testosterone deficiency syndrome in JapanAsian Journal of Andrology, 2011
- Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled studyThe Aging Male, 2010
- Profile of Serum Testosterone Levels after Application of Testosterone Ointment (Glowmin) and Its Clinical Efficacy in Late-Onset Hypogonadism PatientsThe Journal of Sexual Medicine, 2008
- Investigation, Treatment, and Monitoring of Late‐Onset Hypogonadism in Males: ISA, ISSAM, and EAU RecommendationsJournal of Andrology, 2006
- ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: Scientific background and rationaleThe Aging Male, 2005
- The clinical relevance of sex hormone levels and sexual activity in the ageing maleBJU International, 2002
- Investigation, treatment and monitoring of late-onset hypogonadism in males.Official Recommendations of ISSAMThe Aging Male, 2002
- AndropauseMaturitas, 2000
- A new ‘aging males’ symptoms' rating scaleThe Aging Male, 1999